Tag Archives: Pharma
Value-Based Pricing Could Counter Innovation, Says UK Think Tank
The UK government’s proposals to introduce value-based pricing (VBP) — which aims to create a stronger link between the price the National Health Service pays for a medicine and the value it delivers (and in the process, ostensibly, further incentivize therapeutic innovation) — could actually serve to ‘hinder’ innovation, according to a UK think tank.
Posted in Europe, Global, R&D, pricing Also tagged innovation, PPRS, reimbursement, Stockholm Network, UK, value-based pricing Leave a comment
Industry Reactions to Japan Earthquake Crisis
As a dazed Japan copes with the aftermath of the Tohoku earthquake, Japanese pharma companies have been quick to offer donations of both money and medical supplies and help with aid efforts. Takeda has pledged 300m Japanese Yen ($3.6m) to the Japanese Red Cross Society to help the emergency relief fund, as well as offering [...]
Posted in Global Also tagged crisis, deficit, earthquake, healthcare, Japan, tsunami Leave a comment
Croatia: A New Hope for European Pharma?
With Croatia’s potential accession to the EU gathering pace, Beth Kennedy looks at the implications for pharma.
The growth in overall healthcare expenditure in Croatia is slow and the percentage of GDP is expected to remain the same, but the country’s accession to the EU means that European pharma would have access to cheap products [...]
Posted in Emerging Markets, Europe, Global, Guest Blog, Market Access, healthcare Also tagged Croatia, EU Leave a comment

The Most Influential Pharma Leader Or Institution?